SPL 1.01% 10.0¢ starpharma holdings limited

Hahahaha. Sure mate. So we can add to the list that it’s the...

  1. 3,447 Posts.
    lightbulb Created with Sketch. 818
    Hahahaha. Sure mate. So we can add to the list that it’s the fault of ‘3rd parties’ and also a ‘change of personnel’ at the FDA. Cool.

    By your reckoning it’s probably also the fault of Starpharma’s paid consultants that influenced the board to fight the FDA for 5 years rather than conduct a new quick and cheap trial.

    Nothing is ever Starpharma’s fault. It’s always the fault of others. So let’s add 3rd parties and consultants to:

    The market
    Shorters
    The TGA
    The FDA
    The MRHA
    Big Pharma
    Newer modern drugs
    Covid
    Starpharma’s partners
    A lack of patients
    Patients not complying with protocols

    P.S. I wonder if we will ever find out who the consultants were that benefited from advising Starpharma from 2019 to 2023 during the FDA saga. I trust there were no related parties.
 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.